Lorie Petty, APRN
Acute Care · Anchorage, AKNPI 1952835290
Payments from drug & device makers
What this record shows
The money is spread across several categories — other (59.0%), food and beverage and education — rather than concentrated in one kind of arrangement. Novartis accounts for 68.4% of it on its own, with 15 other manufacturers making up the rest. 2025 is the largest year on record at $1,323, more than ten times the $55 reported in 2023.
Across 44 payments — averaging $45.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$1K
- AbbVie$120
- Pfizer$99
- Astellas Pharma US Inc$62
- Genentech USA, Inc.$61
- AstraZeneca$56
- plus $234 from 10 others
What the payments were for
- Food & beverage$72036%
- Education$995%
- Other$1,18059%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 22 | $1,367 |
| AbbVie | 4 | $120 |
| Pfizer | 1 | $99 |
| Astellas Pharma US Inc | 2 | $62 |
| Genentech USA, Inc. | 2 | $61 |
| AstraZeneca | 2 | $56 |
| Johnson & Johnson | 2 | $38 |
| Ipsen Biopharmaceuticals, Inc | 1 | $31 |
| E.r. Squibb & Sons, L.L.C. | 1 | $27 |
| Springworks Therapeutics, Inc. | 1 | $26 |
| Mirati Therapeutics, Inc. | 1 | $22 |
| Pharmacosmos Therapeutics Inc. | 1 | $22 |
| Array Biopharma Inc | 1 | $21 |
| Puma Biotechnology, Inc. | 1 | $19 |
| Servier Pharmaceuticals LLC | 1 | $15 |
| Bristol Myers Squibb | 1 | $14 |
How this compares
Too few acute care providers in Alaskato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VerzenioAbemaciclib | 25 | $385,772 |
| EliquisApixaban | 13 | $12,327 |
| Ondansetron OdtOndansetron | 39 | $580 |
| Prochlorperazine Maleate | 32 | $313 |
| Anastrozole | 11 | $271 |
| Gabapentin | 15 | $203 |
| Potassium Chloride | 28 | $171 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 18 | $143 |
| Oxycodone Hcl | 13 | $129 |
| Prednisone | 13 | $69 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $99 | $12,32713 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few acute care providers in Alaskaon file to place this against a meaningful peer group, so we don't.
Other acute care in Anchorage
- Leah HaydenAnchorage$3K
- Micah RobertAnchorage$667
- Jorin CaltAnchorage$335
- Sarah MorehouseAnchorage$292
- Lisa PageAnchorage$261
- Kimberly RevelsAnchorage$253
- Kelly St JohnAnchorage$159
- Geoffrey MittelsteadtAnchorage$127
- Claudia SmithAnchorage$81
- Rosemary TimmermanAnchorage$42
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.